(GRFS) Grifols - Performance 10.1% in 12m
GRFS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-50.61%
#71 in Peer-Group
Rel. Strength
56.60%
#3326 in Stock-Universe
Total Return 12m
10.06%
#55 in Peer-Group
Total Return 5y
-45.75%
#60 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 33.3 |
| P/E Forward | 10.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 9.75 USD |
| 52 Week Low | 6.49 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.17 |
| Buy/Sell Signal +-5 | -0.47 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GRFS (10.1%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: GRFS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GRFS
| Total Return (including Dividends) | GRFS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.83% | 3.15% | 4.01% |
| 3 Months | 44.08% | 17.08% | 17.14% |
| 12 Months | 10.06% | -11.14% | 13.46% |
| 5 Years | -45.75% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | GRFS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 52.7% | 52.1% | 90.3% |
| 3 Months | 95.6% | 79.4% | 97.5% |
| 12 Months | -12.1% | -87.4% | 46.4% |
| 5 Years | -81% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.50 | 5.50% | 4.63% |
| 3 Month | %th75.00 | 23.06% | 23.00% |
| 12 Month | %th73.00 | 23.85% | -3.00% |
| 5 Years | %th70.00 | -30.49% | -74.50% |
FAQs
Does Grifols (GRFS) outperform the market?
Yes,
over the last 12 months GRFS made 10.06%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months GRFS made 44.08%, while XBI made 17.08%.
Performance Comparison GRFS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GRFS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.3% | 4.8% | 26.8% | -3% |
| US NASDAQ 100 | QQQ | 9.4% | 4.6% | 24.8% | -3% |
| German DAX 40 | DAX | 9% | 7.6% | 14.7% | -20% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.2% | 4.3% | 22.4% | -9% |
| Hongkong Hang Seng | HSI | 8.5% | 6% | 4.8% | -25% |
| India NIFTY 50 | INDA | 10.7% | 9.6% | 26.4% | 13% |
| Brasil Bovespa | EWZ | 13.6% | 9.5% | 11.8% | 9% |
GRFS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.7% | 7.1% | 23.5% | -14% |
| Consumer Discretionary | XLY | 8.4% | 5.5% | 34.5% | -8% |
| Consumer Staples | XLP | 11.4% | 9% | 27.8% | 3% |
| Energy | XLE | 6.4% | 4.7% | 34.4% | 8% |
| Financial | XLF | 10.8% | 6.2% | 24.5% | -15% |
| Health Care | XLV | 9.2% | 8.8% | 38.3% | 17% |
| Industrial | XLI | 8.9% | 4.4% | 21% | -13% |
| Materials | XLB | 8.7% | 4.4% | 26.2% | 6% |
| Real Estate | XLRE | 9.6% | 9% | 28.3% | 2% |
| Technology | XLK | 9.5% | 2.2% | 21.7% | -1% |
| Utilities | XLU | 9.3% | 6.2% | 22.8% | -10% |
| Aerospace & Defense | XAR | 8.7% | 2% | 6.8% | -39% |
| Biotech | XBI | 5.7% | 5.7% | 37.1% | 21% |
| Homebuilder | XHB | 6.3% | 0.1% | 33.4% | 11% |
| Retail | XRT | 9.4% | 5.6% | 31.7% | 4% |
GRFS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.8% | 5.53% | 40.7% | 15% |
| Natural Gas | UNG | 11.1% | 15.3% | 52.8% | 12% |
| Gold | GLD | 9.2% | 8.6% | 8.9% | -28% |
| Silver | SLV | 5% | 2.5% | 4.8% | -12% |
| Copper | CPER | -1% | -6.1% | 7.3% | -13% |
GRFS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 10.2% | 8.9% | 32.1% | 14% |
| iShares High Yield Corp. Bond | HYG | 9.9% | 7.7% | 29.8% | 1% |